Am J Psychiatry 1987; 144:1071-1073
Copyright © 1987 by American Psychiatric Association
An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type
FW Reimherr, PH Wender, DR Wood and M Ward
To elucidate the role of catecholamines in attention deficit disorder, the
authors conducted an open 8-week trial of L-tyrosine in 12 adults with
attention deficit disorder, residual type. Eight showed marked to moderate
clinical response in 2 weeks; at 6 weeks these eight developed tolerance,
suggesting that L-tyrosine is not useful in attention deficit disorder,
residual type.
